Application of bioaffinity mass spectrometry for analysis of ligands

Therapeutic Drug Monitoring

Volumn 27, Issue 6, 2005, Pages 694-699

  Zhu, Yusheng ^a   Valdes Jr , Roland ^a   Jortani, Saeed A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bioaffinity; Ligands analysis; SELDI TOF mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; DNA BINDING PROTEIN; GLYCOCONJUGATE; LIGAND; OLIGONUCLEOTIDE; PROTEIN A; PROTEIN G; RNA BINDING PROTEIN;

AFFINITY CHROMATOGRAPHY; ANTIBODY AFFINITY; ANTIBODY SCREENING; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMOBILIZATION; LIGAND BINDING; MASS SPECTROMETER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; RADIOIMMUNOASSAY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; WESTERN BLOTTING; BIOLOGICAL MODEL; MASS SPECTROMETRY; METHODOLOGY; PROTEIN BINDING; REVIEW;

LIGANDS; MODELS, BIOLOGICAL; PROTEIN BINDING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33646832338     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ftd.0000179851.32093.dc     Document Type: Conference Paper

References (34)

1. Zhu Y, Jortani SA, Simmons CQ, et al. A novel antibody screening technique using protein analysis by SELDI-TOF mass spectrometry. Clin Chem. 2004;50:A33.
2. Xiao Z, Adam BL, Cazares LH, et al. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res. 2001;61:6029-6033.
3. Bane TK, LeBlanc JF, Lee TD, et al. DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation. Nucleic Acids Res. 2002;30:e69.
4. Adilakshmi T, Laine RO. Ribosomal protein S25 mRNA partners with MTF-1 and La to provide a p53-mediated mechanism for survival or death. J Biol Chem. 2002;277:4147-4151.
5. Howard JC, Heinemann C, Thatcher BJ, et al. Identification of collagen-binding proteins in Lactobacillus spp. with surface-enhanced laser desorption/ionization-time of flight ProteinChip® technology. Appl Environ Microbiol. 2000;66:4396-4400.
6. Caputo E, Camarca A, Moharram R, et al. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach. Biochemistry. 2003;42:6169-6178.
7. Mangé A, Béranger F, Peoch K, et al. Alpha- and beta-cleavages of the amino-terminus of the cellular prion protein. Biol Cell. 2004;96:125-132.
8. Schweigert FJ, Wirth K, Raila J. Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay. Proteome Sci. 2004;2:5.
9. Frears ER, Stephens DJ, Walters CE, et al. The role of cholesterol in the biosynthesis of β-amyloid. Neuroreport. 1999;10:1699-1705.
10. Wakabayashi H, Kuwata H, Yamauchi K, et al. No detectable transfer of dietary lactoferrin or its functional fragments to portal blood in healthy adult rats. Biosci Biotechnol Biochem. 2004;68:853-860.
11. Beher D, Wrigley JD, Owens AP, et al. Generation of C-terminally truncated amyloid-beta peptides is dependent on gamma-secretase activity. J Neurochem. 2002;82:563-575.
12. Amaar YG, Thompson GR, Linkhart TA, et al. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem. 2002;277:12053-12060.
13. Grus FH, Joachim SC, Pfeiffer N. Analysis of complex autoantibody repertoires by surface-enhanced laser desorption/ionization-time of flight mass spectrometry. Proteomics. 2003;3:957-961.
14. Mannes AJ, Martin BM, Yang H-YT, et al. Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain. 2003;102:251-256.
15. Diamond DL, Kimball JR, Krisanaprakornkit S, et al. Detection of beta-defensins secreted by human oral epithelial cells. J Immunol Methods. 2001;256:65-76.
16. Xiao Z, Jiang X, Beckett ML, et al. Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay. Protein Expr Purif. 2000;19:12-21.
17. Lewczuk P, Esselmann H, Groemer TW, et al. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease. Biol Psychiatry. 2004;55:524-530.
18. Netzer WJ, Dou F, Cai D, et al. Gleevec inhibits beta-amyloid production but not Notch cleavage. Proc Natl Acad Sci USA. 2003;100:12444-12449.
19. Sheng JG, Bora SH, Xu G, et al. Lipopolysaccharide-induced- neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis. 2003;14:133-145.
20. Vehmas AK, Borchelt DR, Price DL, et al. β-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based Protein-Chip technology. DNA Cell Biol. 2001;20:713-721.
21. Lewczuk P, Esselmann H, Meyer M, et al. The amyloid-beta (ABeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated ABeta peptide. Rapid Commun Mass Spectrom. 2003;17:1291-1296.
22. Wadsworth JT, Somers KD, Stack BC Jr, et al. Identification of patients with head and neck cancer using serum protein profiles. Arch Otolaryngol Head Neck Surg. 2004;130:98-104.
23. Rosty C, Christa L, Kuzdzal S, et al. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 2002;62:1868-1875.
24. Uno F, Sasaki J, Nishizaki M, et al. Atk myristoylation of the Fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res. 2004;64:2969-2976.
25. Ueki A, Isozaki Y, Hatayama T, et al. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals. Clin Exp Immunol. 2002;129:556-561.
26. Latchman DS. Transcription Factor: A Practical Approach. London: Oxford University Press, 1999.
27. Gadgil H, Jurado LA, Jarrett HW, et al. DNA affinity chromatography of transcription factors. Anal Biochem. 2001;290:147-178.
28. Forde CE, Gonzales AD, Smessaert JM, et al. A rapid method to capture and screen for transcription factors by SELDI mass spectrometry. Biochem Biophys Res Commun. 2002;290:1328-1335.
29. Bischoff SR, Kahn MB, Powell MD, et al. SELDI-TOF-MS analysis of transcriptional activation protein binding to response elements regulating carcinogenesis enzymes. Int J Mol Sci. 2002;3:1027-1038.
30. Melamed P, Koh M, Preklathan P, et al. Multiple mechanisms for Pitx-1 transactivation of a luteinizing hormone beta subunit gene. J Biol Chem. 2002;277:26200-26207.
31. D'Costa SS, Romer TG, Boyle MDP. Analysis of expression of a cytosolic enzyme on the surface of Streptococcus pyogenes. Biochem Biophys Res Commun. 2000;278:826-832.
32. Bundy J, Fenselau C. Lectin-based affinity capture for MALDI-MS analysis of bacteria. Anal Chem. 1999;71:1460-1463.
33. Bundy J, Fenselau C. Lectin and carbohydrate affinity capture surfaces for mass spectrometric analysis of microorganisms. Anal Chem. 2001;73:751-757.
34. Tseng K, Wang H, Lebrilla CB. Identification and structural elucidation of lectin-binding oligosaccharides by bioaffinity matrix-assisted laser desorption/ionization Fourier transform mass spectrometry. Anal Chem. 2001;73:3556-3561.